NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • A Guide to What We Do
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
        • OUR 20 RESEARCH THEMES

        • Antimicrobial Resistance and Modernising Microbiology
        • Cardiovascular
        • Clinical Informatics and Big Data
        • Diabetes and Metabolism
        • Gastroenterology and Mucosal Immunity
        • Genomic Medicine
        • Haematology and Stem Cells
        • Imaging
        • Molecular Diagnostics
        • Multi-Modal Cancer Therapies
        • Multi-Morbidity and Long-Term Conditions
        • Musculoskeletal
        • Neurological Conditions
        • Obesity, Diet and Lifestyle
        • Partnerships for Health, Wealth and Innovation
        • Respiratory
        • Stroke and Vascular Dementia
        • Surgical Innovation and Evaluation
        • Technology and Digital Health
        • Vaccines for Emerging and Endemic Diseases
        • Oxford Biomedical Research Centre activities during COVID-19
  • Patient & Public Involvement
    • Getting involved with research
    • Researcher Guidance
    • Post an opportunity for patient and public involvement
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • What Can We Do For Your Organisation?
    • Who Do We Work With?
    • IP and Licensing
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > Other News > Study analyses gender parity in Oxford BRC authorship

Study analyses gender parity in Oxford BRC authorship

30 March 2021 · Listed under Other News

A study conducted by NIHR Oxford Biomedical Research Centre (BRC) researchers has shown that while there are positive trends in terms of the number of women authoring the BRC’s scientific papers, the proportion of female authors is significantly lower than male ones across all categories of authorship.

Nonetheless, the paper, published on the open-access online journal BMJ Open, found that despite the proportion of male authors being significantly higher across all six categories of authorship analysed, the proportions of male and female senior (last) authors was comparable to their respective proportions as principal investigators in the BRC.

“These findings suggest positive trends and convincing evidence that the NIHR Oxford BRC doing very well in gender parity in the most senior authorship category,” said Dr Lorna Henderson, the BRC’s Senior Manager and an author on the paper.

“We believe that this study offers an important benchmark on gender equity in scientific authorship for other NIHR-funded BRCs and organisations in England. However more work is required in this field.”

The paper found that male corresponding authors were more likely to publish articles in prestigious journals with high impact factor while both male and female authors at first and last authorship positions publish articles in equally prestigious journals.

This is the first study to investigate gender parity in six categories of scientific authorship: first authors, first corresponding authors, last authors and three joint authorship categories: joint first authors, joint corresponding authors and joint last authors in biomedical research.

Syed Ghulam Sarwar Shah, first author on the paper, said: “While NIHR BRCs routinely collect bibliometric data on publications, this data is not routinely analysed by gender. Our study shows that analysing scientific authorship of NIHR-funded publications is feasible. Retrospective analysis is labour-intensive and has limitations, but there is an opportunity to begin to track authorship by gender prospectively, allowing longitudinal analysis that could prove useful for tracking progress towards gender equity in NIHR BRCs.”

“Speeding up women’s advancement and leadership in translational research is a key objective of the NIHR, so our study could pave the way for tools that can inform strategies to achieve this,” said Vasiliki Kiparoglou, the Oxford BRC’s Chief Operating Officer and an author on the paper.

← BRC training course prepares future healthcare research leaders
Oxford BRC again achieves ISO 9001 audit success →

News

  • Lymph nodes reveal more about mechanisms of autoimmunity 14 June 2022
  • Conference aims to forge collaborations to tackle dementia 9 June 2022
  • Lung function device wins top chemistry Prize 8 June 2022
See full news archive

News Categories

Month Archives

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Sitemap
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2022 NIHR Oxford Biomedical Research Centre